ORNI Insider Trading Activity and SEC Form 4 Filings
ORNI insider trading summary
No open-market insider purchases or sales of Oragenics Inc (ORNI) have been reported on SEC Form 4 in the past 12 months.
Latest ORNI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 31, 2012 | Fred Telling | Director | Buy | $147K (98,111 @ $1.50) |
| Jul 31, 2012 | Christine L Koski | Director | Buy | $2.5M (1,692,123 @ $1.50) |
| Jul 31, 2012 | Koski Family LP | 10% Owner | Buy | $2.5M (1,692,123 @ $1.50) |
| Jul 31, 2012 | Robert C Koski | Director | Buy | $2.5M (1,692,123 @ $1.50) |
| Jul 31, 2012 | Beverly Koski | 10% Owner | Buy | $2.5M (1,692,123 @ $1.50) |
| Jul 31, 2012 | Thomas L Koski | 10% Owner | Buy | $2.5M (1,692,123 @ $1.50) |
| Jul 31, 2012 | Randal J Kirk | 10% Owner | Buy | $1.3M (857,555 @ $1.50) |
| Jul 31, 2012 | Intrexon Corp | 10% Owner | Buy | $1.3M (857,555 @ $1.50) |
| Mar 23, 2012 | Thomas L Koski | 10% Owner | Buy | $0 (6,285,619 @ $0.00) |
| Mar 23, 2012 | Robert C Koski | Director | Buy | $0 (6,285,619 @ $0.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.